Bristol Myers Squibb - Global Biopharmaceutical Company
Our Commitment
Read our CEO's message to employees on addressing health disparities and diversity.
BMS Foundation, PRIDE ALLIANCE Fund Study to Address Healthcare Disparities
The COLORS Training Program aims to educate oncologists on healthcare disparities experienced in the LGBTQ+ community.
BMS to Acquire MyoKardia
We announced our agreement to acquire MyoKardia, whose portfolio of pipeline drug candidates includes mavacamten, a potential first-in-class medicine that shows compelling data in the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy. Click here for an overview.
Emmy winner Sterling K. Brown explores cancer survivorship during a global pandemic.
Moving forward.
Together.
We’re looking for people who want to change lives.В Join us as we transform patients’ lives through science.В
Learn more about how we strive to produce sustained strong performance and shareholder value.
Looking for Answers?
Quick links to helpful resources.